共 50 条
- [1] Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (04): : 493 - 505
- [2] The pharmacokinetics of dalbavancin in subjects with mild, moderate, or severe hepatic impairment [J]. Critical Care, 12 (Suppl 2):
- [4] Pharmacokinetics of Voclosporin in Renal Impairment and Hepatic Impairment [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (12): : 1303 - 1312
- [6] Asenapine Pharmacokinetics in Hepatic and Renal Impairment [J]. Clinical Pharmacokinetics, 2011, 50 : 471 - 481
- [8] Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron [J]. Clinical Drug Investigation, 2013, 33 : 11 - 23
- [9] Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin [J]. Clinical Pharmacokinetics, 2011, 50 : 253 - 265